Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Iowa by County

Non-Hodgkin Lymphoma (All Stages^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Count

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


Iowa7


US (SEER+NPCR)1


Polk County7


Linn County7


Scott County7


Black Hawk County7


Johnson County7


Pottawattamie County7


Dubuque County7


Woodbury County7


Story County7


Cerro Gordo County7


Dallas County7


Clinton County7


Warren County7


Muscatine County7


Des Moines County7


Wapello County7


Marshall County7


Marion County7


Jasper County7


Lee County7


Sioux County7


Benton County7


Boone County7


Plymouth County7


Bremer County7


Carroll County7


Washington County7


Webster County7


Clay County7


Clayton County7


Mahaska County7


Tama County7


Dickinson County7


Henry County7


Jefferson County7


Fayette County7


Hardin County7


Page County7


Buchanan County7


O'Brien County7


Delaware County7


Franklin County7


Jackson County7


Butler County7


Cedar County7


Iowa County7


Kossuth County7


Wright County7


Harrison County7


Jones County7


Winneshiek County7


Buena Vista County7


Cherokee County7


Floyd County7


Madison County7


Emmet County7


Cass County7


Decatur County7


Crawford County7


Greene County7


Mills County7


Hamilton County7


Hancock County7


Mitchell County7


Poweshiek County7


Fremont County7


Grundy County7


Howard County7


Montgomery County7


Adair County7 Adams County7 Allamakee County7 Appanoose County7 Audubon County7 Calhoun County7 Chickasaw County7 Clarke County7 Davis County7 Guthrie County7 Humboldt County7 Ida County7 Keokuk County7 Louisa County7 Lucas County7 Lyon County7 Monona County7 Monroe County7 Osceola County7 Palo Alto County7 Pocahontas County7 Ringgold County7 Sac County7 Shelby County7 Taylor County7 Union County7 Van Buren County7 Wayne County7 Winnebago County7 Worth County7

Notes:
Created by statecancerprofiles.cancer.gov on 10/12/2024 1:48 pm.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. The Average Annual Percent Change (AAPC) is based on the APCs calculated by Joinpoint. Due to data availability issues, the time period used in the calculation of the joinpoint regression model may differ for selected counties.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) Summary/Historic Combined Summary Stage (2004+).
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Φ Rural-Urban Continuum Codes provided by the USDA.
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2023 submission.
7 Source: SEER November 2023 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with SEER November 2023 data.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.